Case no. | Gender/Age | Etiology | Nodule designation | Size of tumor nodule (mm) | Gradinga | Growth pattern# |
---|---|---|---|---|---|---|
1 | M/60 | HBV | i ii | 25 15 | 2 2 | T T |
2 | M/56 | HBV | i ii | 35 30 | 2 2 | T T + A |
3 | M/58 | HBV | i ii iii iv | 50 30 20 10 | 2 2 2 3 | T + A A + T T T |
4 | M/59 | HBV | i ii | 22 18 | 3 2 | T A + T |
5 | M/57 | HCV | i ii | 40 30 | 2 2 | T T |
6 | M/51 | HBV | i ii | 22 10 | 2 2 | T T |
7 | M/66 | HBV | i ii | 63 14 | 2 3 | T T |
8 | M/49 | HBV | i ii iii | 25 20 12 | 2 2 3 | T T T |
9 | M/50 | HCV | i ii | 40 20 | 2 2 | T A + T |
10 | M/65 | HBV | i ii iii | 45 20 15 | 2 2 3 | A + T T T |
11 | M/60 | HBV | i ii | 50 25 | 3 2 | T T |
12 | M/55 | HBV | i ii | 20 10 | 3 2 | T T |
13 | M/58 | HBV | i ii iii | 35 25 20 | 2 2 2 | T T T |
14 | M/46 | HBV | i ii | 20 15 | 2 2 | T T |
15 | M/63 | ALD | i ii iii | 30 25 25 | 3 2 3 | T T T |
16 | M/65 | HCV | i ii | 45 18 | 3 3 | T T |
17 | M/53 | HBV | i ii iii | 20 13 13 | 2 3 2 | T + A T T |
18 | M/53 | HBV | i ii | 34 10 | 2 3 | T + A T |
19 | F/60 | HBV | i ii iii | 40 20 10 | 2 2 2 | T + A T T |
20 | M/63 | HBV | i ii | 45 40 | 2 2 | T T |
21 | F/60 | cryptogenic | i ii | 50 30 | 2 2 | T T |